Pharmacological inhibition of the CoQ-FSP1 axis re-sensitizes KEAP1-deficient lung cancer tumors, which are inherently resistant to radiotherapy, in part, by inducing ferroptosis. This evidence concerns the gene KEAP1 and lung cancer.